O0027 Rotigotine transdermal patch provides continuous efficacy in patients with moderate to severe idiopathic restless legs syndrome – 24 month results from a multi-national, multi-centre, open-label, follow-up trial
Keyword(s):
Keyword(s):
2011 ◽
Vol 10
(8)
◽
pp. 710-720
◽
2007 ◽
Vol 8
(9)
◽
pp. 1329-1335
◽
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 14
(1)
◽
pp. 15-25
◽